GlassScriptPhysician profile
Ashleigh E Ledet
NPI 1386228716
$1,412.90
in general payments reported to CMS, 2019-2025
11 companies · $948 in 2025
The $948 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.17 · 2022: $33.79 · 2023: $257 · 2024: $154 · 2025: $948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $455.99 | 2023-2025 | Nemluvio |
| Abbvie INC. | $273.63 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $199.33 | 2025 | Dupixent |
| Genzyme Corporation | $152.14 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $92.77 | 2021-2024 | Blu-U, Odomzo |
| Novartis Pharmaceuticals Corporation | $78.14 | 2023-2025 | |
| Pfizer INC. | $63.46 | 2022-2025 | |
| Leo Pharma INC. | $45.05 | 2024-2025 | Adbry |
| Incyte Corporation | $21.98 | 2025 | Opzelura |
| Janssen Biotech, INC. | $15.53 | 2024 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $14.88 | 2024 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashleigh Ledet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.